CHEMED CORP (CHE) Stock Fundamental Analysis

NYSE:CHE • US16359R1032

478.54 USD
+3.13 (+0.66%)
At close: Feb 23, 2026
478.54 USD
0 (0%)
After Hours: 2/23/2026, 8:04:00 PM
Fundamental Rating

7

CHE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. CHE gets an excellent profitability rating and is at the same time showing great financial health properties. CHE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • CHE had positive earnings in each of the past 5 years.
  • CHE had a positive operating cash flow in each of the past 5 years.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

  • CHE has a better Return On Assets (17.17%) than 100.00% of its industry peers.
  • CHE's Return On Equity of 25.89% is amongst the best of the industry. CHE outperforms 91.09% of its industry peers.
  • CHE has a Return On Invested Capital of 21.27%. This is amongst the best in the industry. CHE outperforms 97.03% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHE is significantly above the industry average of 8.93%.
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROIC 21.27%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • CHE has a Profit Margin of 11.02%. This is amongst the best in the industry. CHE outperforms 96.04% of its industry peers.
  • In the last couple of years the Profit Margin of CHE has grown nicely.
  • CHE has a Operating Margin of 14.60%. This is amongst the best in the industry. CHE outperforms 87.13% of its industry peers.
  • CHE's Operating Margin has improved in the last couple of years.
  • CHE has a Gross Margin of 32.88%. This is in the better half of the industry: CHE outperforms 63.37% of its industry peers.
  • CHE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
  • CHE has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CHE has been reduced compared to 5 years ago.
  • There is no outstanding debt for CHE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 12.26 indicates that CHE is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CHE (12.26) is better than 96.04% of its industry peers.
  • CHE has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • CHE has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. CHE outperforms 93.07% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that CHE is not too dependend on debt financing.
  • The Debt to Equity ratio of CHE (0.00) is better than 86.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.26
ROIC/WACC2.44
WACC8.72%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that CHE should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.35, CHE is in line with its industry, outperforming 50.49% of the companies in the same industry.
  • CHE has a Quick Ratio of 1.33. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.33, CHE is in line with its industry, outperforming 55.45% of the companies in the same industry.
  • CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.33
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.97%.
  • Measured over the past years, CHE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.64% on average per year.
  • Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 6.45% in the last year.
  • CHE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.63% yearly.
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.76% on average over the next years.
  • The Revenue is expected to grow by 5.01% on average over the next years.
EPS Next Y-3.31%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
EPS Next 5Y6.76%
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.09%
Revenue Next 5Y5.01%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 21.75, the valuation of CHE can be described as rather expensive.
  • 67.33% of the companies in the same industry are more expensive than CHE, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.64. CHE is around the same levels.
  • CHE is valuated rather expensively with a Price/Forward Earnings ratio of 18.65.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than 65.35% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.75. CHE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.75
Fwd PE 18.65
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHE is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 68.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.8
EV/EBITDA 15.22
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.05
EPS Next 2Y5.31%
EPS Next 3Y6.13%

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.51%, CHE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.49, CHE pays a better dividend. On top of this CHE pays more dividend than 81.19% of the companies listed in the same industry.
  • With a Dividend Yield of 0.51, CHE pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.51%

5.2 History

  • The dividend of CHE is nicely growing with an annual growth rate of 8.02%!
  • CHE has paid a dividend for at least 10 years, which is a reliable track record.
  • CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CHE pays out 11.01% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.01%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

CHEMED CORP

NYSE:CHE (2/23/2026, 8:04:00 PM)

After market: 478.54 0 (0%)

478.54

+3.13 (+0.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28
Earnings (Next)02-25
Inst Owners101.64%
Inst Owner Change42.52%
Ins Owners1.52%
Ins Owner Change-1.18%
Market Cap6.78B
Revenue(TTM)2.53B
Net Income(TTM)278.81M
Analysts82.5
Price Target566.61 (18.4%)
Short Float %4.66%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield 0.51%
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP11.01%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.99%
Min EPS beat(2)-15.11%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-4.45%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)2
Avg EPS beat(8)-3.19%
EPS beat(12)4
Avg EPS beat(12)-2.23%
EPS beat(16)8
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)2
Avg Revenue beat(16)-1.24%
PT rev (1m)-3.27%
PT rev (3m)-3.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.01%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 21.75
Fwd PE 18.65
P/S 2.68
P/FCF 18.8
P/OCF 16.15
P/B 6.29
P/tB 20.86
EV/EBITDA 15.22
EPS(TTM)22
EY4.6%
EPS(NY)25.66
Fwd EY5.36%
FCF(TTM)25.46
FCFY5.32%
OCF(TTM)29.64
OCFY6.19%
SpS178.72
BVpS76.04
TBVpS22.94
PEG (NY)N/A
PEG (5Y)2.05
Graham Number194.01
Profitability
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROCE 27.75%
ROIC 21.27%
ROICexc 23.56%
ROICexgc 62.89%
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
FCFM 14.24%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexgc growth 3Y-5.61%
ROICexgc growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.02%
Cap/Sales 2.34%
Interest Coverage 250
Cash Conversion 96.74%
Profit Quality 129.28%
Current Ratio 1.35
Quick Ratio 1.33
Altman-Z 12.26
F-Score7
WACC8.72%
ROIC/WACC2.44
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
EPS Next Y-3.31%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
EPS Next 5Y6.76%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.09%
Revenue Next 5Y5.01%
EBIT growth 1Y-7.92%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year14.67%
EBIT Next 3Y10.29%
EBIT Next 5Y9.62%
FCF growth 1Y39.38%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y30.35%
OCF growth 3Y10.6%
OCF growth 5Y6.75%

CHEMED CORP / CHE FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 4 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 9 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 9 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to decline by -3.31% in the next year.